Novo Nordisk A/S (NYSE:NVO)

99.65
Delayed Data
As of 4:01pm ET
 -0.74 / -0.74%
Today’s Change
91.51
Today|||52-Week Range
122.16
-11.03%
Year-to-Date
Top Analyst Reports for Novo Nordisk, Suncor Energy, & Nasdaq
1:05pm / Zacks.com - Paid Partner Content
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
Sep 20 / Zacks.com - Paid Partner Content
This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?
Sep 27 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close100.39
Today’s open100.20
Day’s range99.58 - 100.72
Volume1,068,248
Average volume (3 months)1,565,084
Market cap$170.3B
Data as of 4:01pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)+19.70%
Earnings growth (this year)+4.55%
Earnings growth (next 5 years)+16.50%
Revenue growth (last year)+15.27%
P/E ratio34.2
Price/Sales11.53
Price/Book20.63

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.08-0.15%
NVSNovartis-0.60-0.78%
BMYBristol-Myers Squibb-0.59-0.82%
MRKMerck-0.46-0.53%
Data as of 4:02pm ET, 09/30/2022

Financials

Next reporting dateNovember 2, 2022
EPS forecast (this quarter)$0.84
Annual revenue (last year)$22.4B
Annual profit (last year)$7.6B
Net profit margin33.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bagsværd, Capital Region

Forecasts